OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
IAN.CD58

Ianthus Capital Holdings Inc

Healthcare Facilities & ServicesVerified

The company's capital structure is highly leveraged, with total liabilities of $359.03 million and total equity of -$103.04 million, resulting in a debt-to-equity ratio of -1.88. Liquidity is constrained, as evidenced by a current ratio of 0.71 and negative free cash flow of -$44.83 million. The negative net income of -$40.20 million and operating loss of -$15.42 million indicate significant operational challenges, despite a gross profit of $65.70 million. Profitability metrics are mixed. The company's return on equity is 39.02%, which is unusually high given the negative equity, suggesting a distortion in the metric due to the negative denominator. Return on assets is -15.71%, indicating that the company is not generating returns on its asset base. These figures are not directly comparable to industry medians due to the company's unique financial position, but the negative ROA is a red flag for asset efficiency. The company operates in six U.S. states, with approximately 40 dispensaries and eight cultivation and/or processing facilities. Revenue concentration data is not provided, but the multi-state model suggests geographic diversification. However, the cannabis industry is highly regulated and state-specific, which introduces regulatory and operational risks. Growth trajectory is uncertain. The company reported revenue of $143.99 million in the latest period, but the outlook for the current and next fiscal years is not provided. The negative operating cash flow of $3.15 million and capital expenditure of -$23.91 million suggest ongoing investment in operations, but the financial sustainability of this strategy is questionable. Risk factors include liquidity constraints and the potential for dilution, although the risk of dilution is currently assessed as low. The company's negative net income and operating cash flow increase the risk of further equity issuance to fund operations. The risk assessment highlights that net cash is negative after subtracting total debt, indicating a liquidity risk. Recent events include the latest financial results showing a revenue of $78.38 million and an EPS of -$0.42, according to analyst estimates. These figures reflect the company's ongoing financial challenges and the need for continued monitoring of its operational and financial performance.

30-day price · IAN.CD+0.00 (+0.0%)
Low$0.01High$0.01Close$0.01As of17 May, 00:00 UTC
Profile
CompanyIanthus Capital Holdings Inc
TickerIAN.CD
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. iAnthus Capital Holdings, Inc. is a vertically integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities, and a developer, producer, and distributor of branded cannabis products in the United States.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.

The company's capital structure is highly leveraged, with total liabilities of $359.03 million and total equity of -$103.04 million, resulting in a debt-to-equity ratio of -1.88. Liquidity is constrained, as evidenced by a current ratio of 0.71 and negative free cash flow of -$44.83 million. The negative net income of -$40.20 million and operating loss of -$15.42 million indicate significant operational challenges, despite a gross profit of $65.70 million. Profitability metrics are mixed. The company's return on equity is 39.02%, which is unusually high given the negative equity, suggesting a distortion in the metric due to the negative denominator. Return on assets is -15.71%, indicating that the company is not generating returns on its asset base. These figures are not directly comparable to industry medians due to the company's unique financial position, but the negative ROA is a red flag for asset efficiency. The company operates in six U.S. states, with approximately 40 dispensaries and eight cultivation and/or processing facilities. Revenue concentration data is not provided, but the multi-state model suggests geographic diversification. However, the cannabis industry is highly regulated and state-specific, which introduces regulatory and operational risks. Growth trajectory is uncertain. The company reported revenue of $143.99 million in the latest period, but the outlook for the current and next fiscal years is not provided. The negative operating cash flow of $3.15 million and capital expenditure of -$23.91 million suggest ongoing investment in operations, but the financial sustainability of this strategy is questionable. Risk factors include liquidity constraints and the potential for dilution, although the risk of dilution is currently assessed as low. The company's negative net income and operating cash flow increase the risk of further equity issuance to fund operations. The risk assessment highlights that net cash is negative after subtracting total debt, indicating a liquidity risk. Recent events include the latest financial results showing a revenue of $78.38 million and an EPS of -$0.42, according to analyst estimates. These figures reflect the company's ongoing financial challenges and the need for continued monitoring of its operational and financial performance.
Key takeaways
  • The company is highly leveraged with a debt-to-equity ratio of -1.88 and negative equity of -$103.04 million.
  • Despite a gross profit of $65.70 million, the company reported a net loss of -$40.20 million and an operating loss of -$15.42 million.
  • The company operates in six U.S. states with a vertically integrated model, but revenue concentration data is not provided.
  • Liquidity is constrained, with a current ratio of 0.71 and negative free cash flow of -$44.83 million.
  • The company's return on assets is -15.71%, indicating poor asset efficiency.
  • The risk of dilution is currently assessed as low, but the company's financial position may necessitate further equity issuance.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$144.0M
Gross profit$65.7M
Operating income-$15.4M
Net income-$40.2M
R&D
SG&A
D&A
SBC
Operating cash flow$3.1M
CapEx-$23.9M
Free cash flow-$44.8M
Total assets$256.0M
Total liabilities$359.0M
Total equity-$103.0M
Cash & equivalents
Long-term debt$194.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book-$103.0M
Net cash-$194.0M
Current ratio0.7
Debt/Equity-1.9
ROA-15.7%
ROE39.0%
Cash conversion-8.0%
CapEx/Revenue-16.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Pharmaceuticals · cohort 25 companies
MetricIAN.CDActivity
Op margin-10.7%18.2% medp25 18.2% · p75 24.6%bottom quartile
Net margin-27.9%14.7% medp25 11.7% · p75 28.1%bottom quartile
Gross margin45.6%19.7% medp25 19.7% · p75 39.8%top quartile
R&D / revenue24.3% medp25 6.6% · p75 24.3%
CapEx / revenue-16.6%4.9% medp25 4.2% · p75 6.3%bottom quartile
Debt / equity-188.0%71.3% medp25 19.0% · p75 91.7%bottom quartile
Observations
IR observations
Last actual EPS-0.42 USD
Last actual revenue78,382,000 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 08:56 UTC#11b8e034
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 20:01 UTCJob: d61b138d